Publish Date :2017-07-12
The United States Food and Drug Administration agency (FDA) has approved Emmaus Life Sciences' Endari (L-glutamine oral drug powder) to lower the serious complexities of debilitating, rare and lifelong genetic blood syndrome, referred as si...
Publish Date :2017-07-11
Within couple of months since CoherusBioScienceswon, there is yet another pharma company attempting to introduce a biosimilar competitor for the AbbVie’s Humira.
Publish Date :2017-07-11
The Food and Drug Administration (FDA) approved a priority review of Lilly’s abemaciclib, this Monday. It facilitates Lilly’s abemaciclib a faster course to sanction. If abemaciclib got approval then it will turn out to be the 3rd rival...
Publish Date :2017-07-07
Mental health services provided by the National Health Service (NHS) is rapidly increasing as firm’s efforts to deal with inadequate funding and rising demand
Publish Date :2017-07-07
The Swiss drug maker, Novartis has signed a big deal with the British company Oxford BioMedica that could garner them around USD 100 million, including a $10 million advance payment
Publish Date :2017-07-07
The top healthcare technology companies worldwide are checking for robotics application in intricate knee surgery, anticipating faster operations and enhanced outcomes post surgery. As often the result of these types of surgeries is patient...
Publish Date :2017-06-28
The National Institute for health and care excellence (NICE) has now released outline guidance encouraging Daxas (roflumilast) for chronic obstructive pulmonary disease (COPD) patients
Publish Date :2017-06-28
Pfizer hits a major setback as the Food and Drug Administration (FDA) has rejected their biosimilar anemia drug. Surprisingly, Pfizer's biosimilar for Amgen's megahit Epogen got rejected for the second time since 2015 by the Food and Drug A...
Publish Date :2017-06-23
On Thursday, Google will urge the United States lawmakers to modify and apprise laws on whether in what way are the customer information stored on several servers situated in other countries are being accessed by governments’ and hoping t...
Publish Date :2017-06-23
The European Commission (EC) has now issued anapproval to Sandoz, Novartis’ generics arm, to sellRixathon for diseases such as non-Hodgkin's lymphoma and rheumatoid arthritis.It is a biosimilar version of Roche's best-seller MabThera(Ritu...